Northrop Grumman is projected to report Q1 2026 revenue of $9.84 billion and earnings per share of $6.08, while the stock's current price of $665.26 sits approximately 12% below the average analyst price target of $757.50.
Investors are primarily focused on the production ramp-up of the B-21 Raider stealth bomber, particularly following successful aerial refueling tests that signal the program's rapid maturation.
Management's commentary on the Sentinel ICBM program will also be critical as the company implements a course correction to address previous cost overruns and technical delays.
With a record backlog exceeding $95 billion, analysts are looking for evidence that major defense programs are successfully transitioning into higher-margin production phases to support the company's 2026 guidance.